Healthcare venture capital fund that specializes in early-stage investments in a broad range of life science opportunities.
Watson Fund, L.P. is a healthcare venture capital fund that specializes in early-stageinvestments in a broad range of life science opportunities. Watson Fund largely investsin opportunities developed and managed by Accelerator Corporation, with reserves setaside for follow-on investments in companies that meet pre-defined milestones.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 13, 2018
Magnolia NeuroSciences
|
Series A | $31M | Biotechnology | — |
Jul 25, 2017
Rodeo Therapeutics
|
Series A | $5.90M | Biotechnology | — |
Dec 12, 2016
ApoGen Biotechnologies
|
Series A | $7M | Biotechnology | — |
Jan 6, 2016
Petra Pharma
|
Series A | $48M | Biotechnology | — |
Watson Fund has had 1 exits. Watson Fund most notable exits include Rodeo Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Mar 30, 2021 | Rodeo Therapeutics | M&A | Biotechnology | Detail |